213,095 Shares in Oscar Health, Inc. $OSCR Bought by Maverick Capital Ltd.

by · The Markets Daily

Maverick Capital Ltd. acquired a new stake in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) during the second quarter, HoldingsChannel reports. The fund acquired 213,095 shares of the company’s stock, valued at approximately $4,569,000.

Several other institutional investors have also added to or reduced their stakes in OSCR. Thrive Capital Management LLC boosted its stake in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after purchasing an additional 1,588,395 shares in the last quarter. Vanguard Group Inc. raised its stake in Oscar Health by 3.7% in the first quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company’s stock worth $258,247,000 after buying an additional 700,469 shares in the last quarter. Swiss National Bank lifted its holdings in Oscar Health by 1.0% in the first quarter. Swiss National Bank now owns 328,200 shares of the company’s stock worth $4,303,000 after buying an additional 3,400 shares during the period. Invesco Ltd. lifted its holdings in Oscar Health by 14.5% in the first quarter. Invesco Ltd. now owns 244,980 shares of the company’s stock worth $3,212,000 after buying an additional 30,954 shares during the period. Finally, Entropy Technologies LP bought a new stake in Oscar Health during the 1st quarter valued at approximately $165,000. 75.70% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

OSCR has been the subject of several research reports. Barclays increased their target price on Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a research report on Monday, November 10th. The Goldman Sachs Group initiated coverage on Oscar Health in a research report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price objective for the company. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a report on Wednesday, October 8th. Zacks Research upgraded shares of Oscar Health from a “strong sell” rating to a “hold” rating in a research note on Monday, October 13th. Finally, Piper Sandler raised shares of Oscar Health from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $13.00 to $25.00 in a research report on Tuesday, November 25th. One investment analyst has rated the stock with a Buy rating, six have issued a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, Oscar Health has a consensus rating of “Reduce” and an average price target of $15.57.

View Our Latest Stock Analysis on Oscar Health

Insider Activity

In other news, CFO Richard Scott Blackley sold 25,135 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $416,989.65. Following the transaction, the chief financial officer owned 1,351,034 shares in the company, valued at approximately $22,413,654.06. This represents a 1.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Adam Mcananey sold 1,852 shares of the stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $30,724.68. Following the sale, the insider owned 179,241 shares in the company, valued at approximately $2,973,608.19. The trade was a 1.02% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 739,472 shares of company stock valued at $12,616,880 over the last ninety days. 24.39% of the stock is currently owned by corporate insiders.

Oscar Health Trading Up 1.9%

Oscar Health stock opened at $15.89 on Friday. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.80. The company has a market capitalization of $4.21 billion, a price-to-earnings ratio of -14.19 and a beta of 1.88. The business’s fifty day simple moving average is $17.81 and its two-hundred day simple moving average is $16.97. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR – Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.55) by $0.02. The firm had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.Oscar Health’s quarterly revenue was up 23.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.22) EPS. As a group, equities analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

See Also

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).